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Renal artery stenosisAbstract Background: Renovascular hypertension due to fibromuscular dysplasia is an uncom-
mon cause of secondary hypertension and is more common in females. This entity is an important
treatable cause of secondary hypertension.
Case presentation: We report the case of a 21-year-old asymptomatic male found to have high
blood pressure on routine checkup. Renal angiogram revealed fibromuscular dysplasia involving
the right renal artery. He underwent percutaneous angioplasty with complete recovery. The single
antihypertensive which he was on was stopped next month.
Conclusion: Fibromuscular dysplasia causing stenosis of renal artery is uncommon. High degree of
suspicion is required for the timely diagnosis and treatment of this potentially treatable cause of
secondary hypertension
 2016 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Renovascular hypertension is one of the most common treat-
able causes of secondary hypertension. The incidence depends
upon the clinical presentation with ranges from <1% in cases
of mild hypertension1 to 10 and 45 percent of white patients
with severe or malignant hypertension.2 The mechanism of
hypertension is activation of the renin angiotensin aldosteronesystem.3 The characteristic features suggesting renovascular
hypertension are hypokalemia, young age of onset and renal
bruit.3 The most common cause of renal artery stenosis
(RAS) is atherosclerosis of the renal artery (75% of all cases).4
Among the patients with renovascular hypertension, fibromus-
cular dysplasia (FMD) constitutes 35 to 50 percent of cases in
children and 5 to 10 percent of cases in adults under the age of
60 years.5,6 This etiological diagnosis is particularly important
because the goal of treatment is cure from hypertension. In
fibromuscular dysplasia, the hypertension is cured or improved
in majority of the patients in contrast to atherosclerotic renal
artery stenosis.7,8ted with
Figure 2 Left renal angiogram.
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We present a case of 21-year-old adult male who was found to
have high blood pressure during routine checkup. He did not
have any symptoms prior to the hospital visit. There was no
family history of hypertension or familial dyslipidemia. His
maximal recorded blood pressure was 230/140 mmHg in both
the arms. All peripheral pulses were palpable with no radio-
radial or radio-femoral delay.
General physical examination did not reveal any abnormal-
ity. His body weight was normal with Body Mass Index of
23.5 kg/m2. The precordial, respiratory and neurological sys-
tem examinations were normal. There were no features of
hypo- or hyperthyroidism and Cushing’s disease. On ausculta-
tion, there was an audible renal artery bruit. Routine blood
investigations including urea, creatinine and serum electrolytes
were normal. His chest X-ray, ECG and echocardiogram were
normal.
We started him on standard anti-hypertensive medications
and did further investigations. As renal artery stenosis was sus-
pected from clinical examination, renal Doppler was per-
formed, which did not reveal any renal artery stenosis but
there was significant discrepancy in the sizes of the right and
left kidneys. The right kidney was 8 cm and left kidney
10 cm in size with normal cortico-medullary differentiation.
Because of low sensitivity of the renal Doppler examination,
arterial stenosis was not ruled out. Since clinical examination
and different kidney sizes were in favor of renal artery stenosis,
we decided to go for invasive renal angiogram.
Renal artery angiogram of right renal artery revealed mul-
tifocal renal FMD with angiographic appearance of strings of
beads (Fig. 1). The left renal artery was normal (Fig. 2).
Subsequently, the patient underwent balloon angioplasty but
due to suboptimal dilatation (Fig. 3), stenting of right renal
artery was performed (Fig. 4). His blood pressure was con-
trolled with only one antihypertensive medication, which wasFigure 1 Right renal angiogram.
Figure 3 Angiogram post ballooning.
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plications and his hospital stay was uneventful.
3. Discussion
Fibromuscular dysplasia is an uncommon cause of arterial dis-
ease that predominantly affects females.9 It is a non-
inflammatory, non-atherosclerotic disease that mostly involves
the renal and carotid arteries but can involve any arterial bed.
Renal artery is involved in around 60–75% of patients.7
Histologically, FMD is classified based on the dominantmale as a cause of renal artery stenosis and secondary hypertension treated with
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Figure 4 Angiogram post stent deployment.
Fibromuscular dysplasia in an adult male 3arterial wall layer involved, namely intimal, medial, and
adventitial (perimedial).10 The most common is the medial
type which accounts for 85% of cases and is characterized
by ‘‘string of beads” appearance. The intimal and adventitial
types constitute 5% and 10% respectively.11 The etiology of
FMD has not been established although a variety of genetic,
mechanical, and hormonal factors have been proposed.7
The common age of renal involvement in FMD is between
15 and 50 years of age. Most commonly, the disease is asymp-
tomatic and is discovered during the routine checkup or while
investigating for some other disease.7 According to the previ-
ous reports, renal FMD accounts for less than 10% of cases
of RAS.3 The commonest presentation of FMD is renovascu-
lar hypertension. The mechanism depends on whether the
stenosis is unilateral (renin-mediated hypertension) or bilateral
(volume depended hypertension).12 Two-thirds of RAS due to
FMD is bilateral.13
Once FMD as a cause of renal artery stenosis is suspected,
and there are various methods of imaging for confirmation of
the diagnosis. Biochemical tests for the diagnosis of RAS by
using renin lack specificity. Renal duplex sonography for the
detection of hemodynamically significant renovascular disease
has a sensitivity of only approximately 50%. The major limita-
tion of the duplex sonography is operator dependency.14 The
advantage is that it is noninvasive and has no apparent side
effects.15 Another advantage is that the measurement of resis-
tive index in the cortical blood vessel can be done. Resistive
index less than 80 showed favorable outcome in a study done
by Radermacher et al.16 Other methods are magnetic reso-
nance angiogram (MRA) and computed tomographic angiog-
raphy (CTA) with the use of high-resolution multi-slice
detector devices.17 The CT imaging has its limitations; the
quality of image depends upon equipment, technique, and
reconstruction of the images, patient-related factors, including
the presence of calcium, the presence of stents, and the ability
to hold one’s breath during imaging.7 MRA is limited by itsPlease cite this article in press as: Bishal KC et al. Fibromuscular dysplasia in an adult
renal artery stenting, The Egypt Heart J (2016), http://dx.doi.org/10.1016/j.ehj.2016frequent association of gadolinium contrast with nephrogenic
systemic fibrosis.18 Despite the invasive nature of investigation
the gold standard in diagnosing FMD is intra-arterial angio-
gram but only as intent to revascularize because of its invasive
nature. The characteristic feature is multifocal stenosis with
the ‘‘string of beads” appearance, which likely indicates the
presence of medial type FMD. Other patterns include tubular
or focal lesions.19
Treatment includes medical management of hypertension
and revascularization, both surgical angioplasty and percuta-
neous angioplasty. Medical management is done in accordance
with the guidelines of the Joint National Committee on pre-
vention, detection, evaluation and treatment of high blood
pressure.20 Almost all the patients require at least one antihy-
pertensive and the initial drug class of choice in FMD is an
angiotensin-converting enzyme (ACE) inhibitor or angiotensin
receptor blocker (ARB).21–23 Revascularization is the treat-
ment of choice in patients in young patients with hypertension
refractory to pharmacological therapy, those who are intoler-
ant to antihypertensive and in those who have lost renal vol-
ume due to ischemic nephropathy.7 There are two modalities
of revascularization - surgical angioplasty and percutaneous
transluminal angioplasty (PTA). There is a lack of data regard-
ing direct comparison of these two modalities. Surgery used to
be method of choice prior to PTA.24,25 Nowadays, PTA has
established itself as a revascularization method of choice with
success rates of 60–80%.24,25 The major advantages are that it
is less costly, less invasive, can be performed as an outpatient
procedure and has a lower morbidity.7 In FMD, unlike the
atherosclerosis, balloon angioplasty is the preferred therapy.7
Routine use of stents in FMD is not recommended; however,
if the dilatation is suboptimal and if renal artery dissection
occurs, stenting can be performed.26,27 Complications of
PTA are around 14% and rarely, renal artery perforation,
dissection or segmental renal infarctions may occur.28,29 In
30–50% of cases, complete resolution of hypertension is
achieved.23,24
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